Villeno, Benjamin, JR.. M.
HRN: 25-85-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/24/2024
10/01/2024
IV
2.25
Q8
Caphr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes